Mabwell (Shanghai) Bioscience Co., Ltd. engages in the research and development, production and sales of therapeutic biological products. Its main product is antibody drugs. Its platform covered antibody drug discovery, pharmaceutical development, quality research control and assurance, medical and clinical operations, and commercial base. The company was founded on May 12, 2017 and is headquartered in Shanghai, China.